JACOBS LEVY EQUITY MANAGEMENT, INC

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in MRVI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,417,084

+$5,118,395 QoQ

Shares Held

1,028,379

+124.1% QoQ

Ownership

0.396%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#36

of 177 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 81% Shared 0% None 19%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. MRVI ranks #25 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,417,084	1,028,379	+124.1%	Shares	Sole	2026-08-14
2026-03-31	$1,298,689	458,901	+184.9%	Shares	Sole	2026-05-15
2025-12-31	$523,549	161,092	-19.0%	Shares	Sole	2026-02-13
2025-09-30	$570,840	198,899	-4.3%	Shares	Sole	2025-11-17
2025-06-30	$500,650	207,739	-57.9%	Shares	Sole	2025-08-14
2025-03-31	$1,090,816	493,582	+437.0%	Shares	Sole	2025-05-15
2024-12-31	$500,904	91,909	+61.0%	Shares	Sole	2025-02-14
2024-03-31	$494,848	57,076	-66.8%	Shares	Sole	2024-05-15
2023-12-31	$1,125,368	171,812	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.